Pacira BioSciences, Inc.
PCRX · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Cross Shawn: Form 4
Insider disclosure · Filed · Report period 30 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- PCRX · 695127100 - Common Stock
Company details and SEC sources
CIK 0001396814 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- PCRX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 2000 Sierra Point Parkway, Suite 900, Brisbane, CA, 94005
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Pacira Pharmaceuticals, Inc. (to 09 Apr 2019), PACIRA INC (to 05 Nov 2008), Blue Acquisition Corp (to 16 Apr 2007)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields